<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01850719</url>
  </required_header>
  <id_info>
    <org_study_id>NL4418.100.13</org_study_id>
    <nct_id>NCT01850719</nct_id>
  </id_info>
  <brief_title>Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients</brief_title>
  <acronym>ESCAPE</acronym>
  <official_title>Cost-effectiveness of Early Surgery Versus Conservative Treatment With Optional Delayed Meniscectomy in Older Patients. A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Onze Lieve Vrouwe Gasthuis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stichting Achmea Gezondheidszor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Onze Lieve Vrouwe Gasthuis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effectiveness of both arthroscopic knee surgery&#xD;
      and physical therapy in the treatment of non-obstructive meniscal injuries in older patients.&#xD;
&#xD;
      The investigators assume equal improvement of physical function in both groups and reduced&#xD;
      costs with conservative treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: Arthroscopic Partial Meniscectomy (APM) is the most performed orthopaedic&#xD;
      procedure and is current standard treatment for patients with meniscal tears. Since&#xD;
      superiority of APM over conservative treatment has not well been described and studies with&#xD;
      direct comparison between APM and conservative treatment are sparse, therefore there is risk&#xD;
      of large healthcare inefficiency.&#xD;
&#xD;
      Study design: Non-inferiority multicenter randomized controlled trial with an economic&#xD;
      evaluation alongside. The study will be conducted by the Orthopaedic Research Consortium&#xD;
      Mid-West Netherlands and performed in 6 clinics, including 2 academic medical centers.&#xD;
&#xD;
      402 patients between 45 and 70 years with Magnetic Resonance Imaging (MRI)-confirmed&#xD;
      symptomatic, non-obstructive meniscal tears will be included. Patients will be assigned to&#xD;
      either APM (n=201) or Physical Therapy (PT; n=201), with optional delayed APM (cross-over)&#xD;
      when conservative treatment has failed. Block randomization will be done stratified for age&#xD;
      and site. Data will be analysed on both intention to treat and per protocol basis.&#xD;
&#xD;
      Measurement points:&#xD;
&#xD;
        -  Patients will be asked to complete questionnaires at baseline and 3, 6, 9, 12, 18, 24&#xD;
           and 60 months.&#xD;
&#xD;
        -  At both 3 and 24 months they will visit the outpatient department for physical&#xD;
           examination.&#xD;
&#xD;
        -  At 24 and 60 months an X-ray will be obtained.&#xD;
&#xD;
      Sample size calculation: 402 patients, based on a power of 90%, an alpha of 0.05, a standard&#xD;
      deviation of 20 points and a non-inferiority threshold of 8 points on the IKDC 'Subjective&#xD;
      Knee Form'. Loss to follow up and cross-over have been taken into account in this&#xD;
      calculation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2013</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>International Knee Documentation Committee 'Subjective Knee Form'</measure>
    <time_frame>3, 6, 12, 24 and 60 months</time_frame>
    <description>Primary outcome will be change in physical function from baseline to 2 years measured by the International Knee Documentation Committee (IKDC) 'Subjective Knee Form', which has been validated for meniscal injuries.&#xD;
In addition, 1) the investigators will perform an economic analysis alongside the Randomized Controlled Trial (RCT) from a societal perspective and a budget impact analysis from societal, government and insurer perspective.&#xD;
2) The primary outcome after 5 years will be investigated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RAND-36 Physical Functional Status Scale</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-5L Quality of life measure</measure>
    <time_frame>3, 6, 9, 12, 18, 24 and 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tegner Activity Scale</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Care Utilization and productivity losses</measure>
    <time_frame>3, 6, 9, 12, 18 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Specific Complaints questionnaire</measure>
    <time_frame>3, 6 ,12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Examination</measure>
    <time_frame>3 and 24 months</time_frame>
    <description>Performance on meniscus specific physical tests, joint line tenderness and the existence of joint effusion in the knee.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS pain score</measure>
    <time_frame>3, 6, 12, 24 and 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Osteoarthritis Outcome Score-Physical functioning Short from (KOOS-PS)</measure>
    <time_frame>60 months</time_frame>
    <description>for physical functioning</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">321</enrollment>
  <condition>Meniscal Tear</condition>
  <arm_group>
    <arm_group_label>Arthroscopic Partial Meniscectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthroscopic Partial Meniscectomy</intervention_name>
    <description>Arthroscopic partial APM is performed within 4 weeks in day-care. No standard physical therapy is prescribed after surgery, as advised by the Dutch Orthopaedic Association Guidelines.</description>
    <arm_group_label>Arthroscopic Partial Meniscectomy</arm_group_label>
    <other_name>APM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Therapy</intervention_name>
    <description>Conservative treatment consist of 16 sessions PT and a home exercise program. These programs are developed for our population, 45-70 years, with a focus on closed-chain strength exercises and cardiovascular exercises.&#xD;
In case conservative treatment has failed, patients can cross-over and delayed APM is then performed. This can be done, from completion of the PT program, during the entire study.</description>
    <arm_group_label>Physical Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients between 45 and 70 years of age at presentation.&#xD;
&#xD;
          -  A meniscal tear visualized on MRI. The meniscal tear can either be isolated or&#xD;
             combined with a partial asymptomatic Anterior Cruciate Ligament (ACL) injury or an&#xD;
             asymptomatic degenerative ACL shown on MRI with no abnormal clinical findings (a&#xD;
             negative Lachman test and Pivot Shift).&#xD;
&#xD;
          -  Mental Competence.&#xD;
&#xD;
          -  Willingness to comply with follow up schedule.&#xD;
&#xD;
          -  Written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Knee locking or trauma leading to acute surgery.&#xD;
&#xD;
          -  One of the following associated injuries on the index knee:&#xD;
&#xD;
               1. A symptomatic partial ACL rupture or any total ACL rupture determined by clinical&#xD;
                  examination (positive Lachman test and/or positive Pivot Shift) and shown on MRI;&#xD;
&#xD;
               2. A complete Posterior Cruciate Ligament (PCL) injury;&#xD;
&#xD;
               3. Cartilage change down to bone; grade 4 of the Kellgren Lawrence Grading Scale for&#xD;
                  Osteoarthritis visualized on X-ray;&#xD;
&#xD;
               4. An injury to the lateral/posterolateral ligament complex with significantly&#xD;
                  increased laxity.&#xD;
&#xD;
          -  A history of knee surgery other than diagnostic arthroscopy on the index knee.&#xD;
&#xD;
          -  Tumors on MRI suspected for a malignancy.&#xD;
&#xD;
          -  Obese patients with Body Mass Index (BMI) &gt; 35.&#xD;
&#xD;
          -  ASA 4-5 patients which can severely interfere with rehabilitation.&#xD;
&#xD;
          -  General disease that effects physical function or systemic medication/abuse of&#xD;
             steroids (e.g., rheumatoid arthritis, psoriatic arthritis, systemic lupus&#xD;
             erythematosus, gout, pseudogout)&#xD;
&#xD;
          -  Any other medical condition or treatment interfering with the completion or assessment&#xD;
             of the trial, e.g. contraindications to MRI or surgery.&#xD;
&#xD;
          -  Drugs or alcohol abuse.&#xD;
&#xD;
          -  Patients unable to speak or read Dutch.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rudolf W Poolman, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Orthopaedic Surgery Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arthur de Gast, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Orthopaedic Surgery Diakonessenhuis, Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thijs ThM van der SChoot, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Dean Board of Directors Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduard LA Mutsaerts, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Victor A van de Graaf, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Orthopaedic Surgery Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gino MM Kerkhoffs, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery Academic Medical Center University of Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julius Wolkenfelt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery St. Lucas Andreas Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurits W van Tulder, professor</last_name>
    <role>Study Director</role>
    <affiliation>Professor of Health Technology Assessment Dept. Health Sciences VU University Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vanessa AB Scholtes, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Research coordinator Dept. of Orthopaedic Surgery Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nienke Wolterbeek, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Research coordinator Dept. of Orthopaedic Surgery St. Antonius Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Camille Neeter, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Neeter Physiotherapy Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ewoud RA van Arkel, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Orthopaedic Surgery MC Haaglanden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medisch Centrum Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <state>Noord Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Lucas Andreas Hospital</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1006 AE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Jan van Goyen</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1075 HN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1090 HM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center University of Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1100 DD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Slotervaart Ziekenhuis</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Haaglanden</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tergooi Ziekenhuis</name>
      <address>
        <city>Hilversum</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sint Elisabeth Hospital</name>
      <address>
        <city>Tilburg</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diakonessenhuis</name>
      <address>
        <city>Utrecht</city>
        <zip>3508 TG</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 7, 2013</study_first_submitted>
  <study_first_submitted_qc>May 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2013</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Onze Lieve Vrouwe Gasthuis</investigator_affiliation>
    <investigator_full_name>Victor van de Graaf</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Tibial meniscus</keyword>
  <keyword>Arthroscopy</keyword>
  <keyword>Meniscectomy</keyword>
  <keyword>Conservative treatment</keyword>
  <keyword>Physical therapy</keyword>
  <keyword>Osteoarthritis knee joint</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 15, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT01850719/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

